Seq #362 Saturday, 13 March 2004

10:15 AM-11:30 AM Hawaii Convention Center Exhibit Hall 1-2, Poster
Oral Therapeutics - Mouthrinses and Fluoride Levels
 
3529  Fluoride Intake from Foods and Beverages in Japanese Children
K. NOHNO, Niigata University, Graduate School of Medical and Dental Sciences, Niigata city, Niigata, Japan, S. SAKUMA, Niigata University Dental Hospital, Department of Oral Health Control, Niigata city, Niigata, Japan, H. KOGA, Tokyo Dental College, Chiba-city, Japan, M. NISHIMUTA, The National Institute of Health and Nutrition, Division of Human Nutrition, shinzyuku, Japan, and H. MIYAZAKI, Niigata University, Graduate School of Medical & Dental Sci, Niigata city, Niigata, Japan
3530  Average Natural Groundwater Fluoride Concentration vs. Soil/Rock Type
M. MALLATT1, E. MOORE1, E. LUTZ1, J. OLDHAM1, K. YODER2, and T. BRANAM3, 1Indiana State Department of Health, Indiana University, Indianapolis, USA, 2Indiana University School of Dentistry, Indianapolis, USA, 3Indiana University, Bloomington, USA
3531  The Effect of Mouthwash on Micronucleus Formation in KB cell
S. SONGWATTANA1, P. TEMCHAROEN2, L. HIMAKOUN2, S. POOMSAWAT3, and W. WEERAPRADIST4, 1Srinakarinwirot University, Faculty of Dentistry, Bangkok, Thailand, 2Mahidol University, Faculty of Science, Bangkok, Thailand, 3Mahidol University, Faculty of Dentistry, Bangkok, Thailand, 4Mahidol University, Bangkok, Thailand
3532  Extended Antimicrobial Activity Of Oral Care Breath Strips
L.D. STURDIVANT1, S. SANTOS1, D. ILG1, M. RUBIN1, P.C. PAN1, L. BORDEN2, and P. ZHANG1, 1Pfizer Inc, Morris Plains, NJ, USA, 2Hill Top Research, Inc, West Palm Beach, FL, USA
3533  Analyses Assessing Plaque/Gingival Health Improvements in a European Population
J. BOWMAN1, A. GREENWOOD1, N. RADLEY2, J. COELHO2, and S. MASON3, 1Hill Top Research, Inc, Miamiville, OH, USA, 2Pfizer Consumer Healthcare, Eastleigh, Hampshire, England, UK, 3Oral Care Business, West Palm Beach, FL, USA
3534  Comparative Antimicrobial Activity of Essential Oil-Containing Oral Care Strips
S. SANTOS1, L. STURDIVANT1, D. ILG1, L. BORDEN2, M. RUBIN1, P. ZHANG1, P.C. PAN1, and M.C. LYNCH1, 1Pfizer Inc, Morris Plains, NJ, USA, 2Hill Top Research, Inc, West Palm Beach, FL, USA

Back to the: Oral Health Research Program

Back to the IADR/AADR/CADR 82nd General Session (March 10-13, 2004)

Top Level Search